Estimating the cost consequence of the early use of botulinum toxin in post-stroke spasticity: Secondary analysis of a randomised controlled trial.
Cameron LindsayIoan HumphreysCeri PhillipsAnand PandyanPublished in: Clinical rehabilitation (2022)
EudraCT(2010-021257-39) and ClinicalTrials.gov-Identifier:NCT01882556.
Keyphrases